Nostics

Nostics is pioneering a novel diagnostic platform that combines Raman spectroscopy, nanotechnology, and a proprietary Large Spectral Foundation Model (AI) to identify pathogens in under 10 minutes at the point of care. Founded in Leiden, Netherlands, the company addresses the critical need for rapid, accurate infection diagnostics to combat antimicrobial resistance and improve patient outcomes. Its portable, cartridge-based system is designed for decentralized settings, requiring no lab infrastructure or specialized skills. Nostics is a private, likely pre-revenue company backed by investors and recognized for its innovative approach with several awards.

Integrated platform combining Raman spectroscopy for pathogen fingerprinting, nanotechnology (SERS) for signal enhancement directly from patient samples, and a proprietary Large Spectral Foundation Model (AI) for real-time identification and few-shot learning.

Nostics competes with established players like BioMérieux (BioFire), Cepheid, and Luminex that offer rapid molecular panels, but these often still require some sample processing and centralized equipment. Its direct competition includes other startups developing novel rapid detection technologies (e.g., using CRISPR, microfluidics). Nostics' key differentiator is the combination of label-free spectroscopy, direct-from-sample detection, and a specialized AI foundation model for microbiology.